Cargando…
Serum metabolite profile associates with the development of metabolic co-morbidities in first-episode psychosis
Psychotic patients are at high risk for developing obesity, metabolic syndrome and type 2 diabetes. These metabolic co-morbidities are hypothesized to be related to both treatment side effects as well as to metabolic changes occurring during the psychosis. Earlier metabolomics studies have shown tha...
Autores principales: | Suvitaival, T, Mantere, O, Kieseppä, T, Mattila, I, Pöhö, P, Hyötyläinen, T, Suvisaari, J, Orešič, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314133/ https://www.ncbi.nlm.nih.gov/pubmed/27845774 http://dx.doi.org/10.1038/tp.2016.222 |
Ejemplares similares
-
42.3 METABOLOMICS APPROACHES TO STUDY METABOLIC CO-MORBIDITIES IN PSYCHOTIC DISORDERS
por: Hyötyläinen, Tuulia, et al.
Publicado: (2018) -
Is It Possible to Predict the Future in First-Episode Psychosis?
por: Suvisaari, Jaana, et al.
Publicado: (2018) -
42.2 INFLAMMATION AND GUT MICROBIOME IN FIRST-EPISODE PSYCHOSIS
por: Suvisaari, Jaana, et al.
Publicado: (2018) -
F166. LOW-GRADE INFLAMMATION IN FIRST-EPISODE PSYCHOSIS IS DETERMINED BY WAIST CIRCUMFERENCE INCREASE
por: Keinänen, Jaakko, et al.
Publicado: (2018) -
Altered Activation of Innate Immunity Associates with White Matter Volume and Diffusion in First-Episode Psychosis
por: Mäntylä, Teemu, et al.
Publicado: (2015)